These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17472028)

  • 1. Risk factor identification and assessment in hypertension and diabetes (RIAHD) study.
    Skrtic S; Niklason A; Leoo T; Hedner T;
    Blood Press; 2006; 15(6):367-74. PubMed ID: 17472028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).
    Naser N; Dzubur A; Durak A; Kulic M; Naser N
    Med Arch; 2016 Jul; 70(4):274-279. PubMed ID: 27703288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of ESC/ESH-Based Written Generic Lifestyle Advice and a Nutraceutical on 24-Hour Blood Pressure in Patients with High-Normal Office Blood Pressure and Low-Moderate Cardiovascular Risk.
    Landolfo M; Spannella F; Poliseno C; Massacesi A; Giulietti F; Festa R; Cavazzin E; Sasso G; Mazza A; Sarzani R
    Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daytime, home and office blood pressures in treated hypertensive patients according to accretion of cardiovascular risk.
    Gasowski J; Szyndler A; Dubiela A; Smiałek K; Chrostowska M; Szczech R; Bieniaszewski L; Grodzicki T; Narkiewicz K
    Blood Press; 2006; 15(6):354-61. PubMed ID: 17472026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure.
    Mancia G; Facchetti R; Bombelli M; Grassi G; Sega R
    Hypertension; 2006 May; 47(5):846-53. PubMed ID: 16567588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and reproducibility of differences between home and ambulatory blood pressure and their relation with hypertensive organ damage.
    Gazzola K; Cammenga M; van der Hoeven NV; van Montfrans GA; van den Born BJH
    J Hum Hypertens; 2017 Sep; 31(9):555-560. PubMed ID: 28382957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study.
    Niiranen TJ; Hänninen MR; Johansson J; Reunanen A; Jula AM
    Hypertension; 2010 Jun; 55(6):1346-51. PubMed ID: 20385970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
    ; ; ; ; ; Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
    Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults.
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
    Chronobiol Int; 2015; 32(10):1329-42. PubMed ID: 26587588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of ambulatory blood pressure: evidence and limits.
    Mancia G; Verdecchia P
    Circ Res; 2015 Mar; 116(6):1034-45. PubMed ID: 25767288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study.
    Grassi G; Cifkova R; Laurent S; Narkiewicz K; Redon J; Farsang C; Viigimaa M; Erdine S; Brambilla G; Bombelli M; Dell'Oro R; Notari M; Mancia G
    Eur Heart J; 2011 Jan; 32(2):218-25. PubMed ID: 21047877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients.
    Bobrie G; Chatellier G; Genes N; Clerson P; Vaur L; Vaisse B; Menard J; Mallion JM
    JAMA; 2004 Mar; 291(11):1342-9. PubMed ID: 15026401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk stratification in primary care patients with arterial hypertension: Results from the Swiss Hypertension Cohort Study (HccH).
    Handschin A; Brighenti-Zogg S; Mundwiler J; Giezendanner S; Gregoriano C; Martina B; Tschudi P; Leuppi JD; Zeller A; Dieterle T
    Eur J Prev Cardiol; 2019 Nov; 26(17):1843-1851. PubMed ID: 31189378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients?: prospective observational study.
    Lehmann MV; Zeymer U; Dechend R; Kaiser E; Hagedorn I; Deeg E; Senges J; Schmieder RE
    Int J Cardiol; 2013 Oct; 168(3):2255-63. PubMed ID: 23474245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of masked hypertension in the general population: the Finn-Home study.
    Hänninen MR; Niiranen TJ; Puukka PJ; Mattila AK; Jula AM
    J Hypertens; 2011 Oct; 29(10):1880-8. PubMed ID: 21841499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study.
    Hansen TW; Jeppesen J; Rasmussen S; Ibsen H; Torp-Pedersen C
    Am J Hypertens; 2006 Mar; 19(3):243-50. PubMed ID: 16500508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Salles GF; Leite NC; Pereira BB; Nascimento EM; Cardoso CR
    J Hypertens; 2013 Nov; 31(11):2176-86. PubMed ID: 24029864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.